CNTB Stock Analysis: Buy, Sell, or Hold?
CNTB - Connect Biopharma Holdings Limited Ordinary Shares
$2.40
-0.15 (-5.88%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When CNTB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNTB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CNTB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CNTB is currently trading at $2.40, which is considered fair relative to its 30-day fair value range of $2.23 to $2.66.
Technical Outlook: Technically, CNTB is in a strong uptrend. Immediate support is located at $2.10, while resistance sits at $2.88. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: CNTB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.90 (+229.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNTB is in a strong uptrend. Immediate support is located at $2.10, while resistance sits at $2.88. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: CNTB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.90 (+229.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.23 -
$2.66
Company Quality Score
52/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
79.2%
Protect Your Profits
Holding CNTB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.9%)
- BULLISH: Trading 229.2% below Wall St target ($7.90)
- CAUTION: Recommendation downgraded due to -5.5% 5-day decline
Fair Price Analysis
30-Day Fair Range
$2.23 -
$2.66
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$0.75
(31.1%)
Support & Resistance Levels
Support Level
$2.10
Resistance Level
$2.88
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.95
Wall Street Target
$7.90
(+229.2%)
Revenue Growth (YoY)
-98.7%
Last updated: February 01, 2026 3:09 AM ET
Data refreshes hourly during market hours. Next update: 4:09 AM
Data refreshes hourly during market hours. Next update: 4:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$85 | 55 HOLD |
Advanced CNTB Option Strategies
Professional options setups generated by AI based on today's CNTB price and gamma walls.
